Kenalog and Minoxidil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Minoxidil (minoxidil). Common drug interactions include anxiety among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Minoxidil. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.



On Jul, 13, 2026

19 people who take Kenalog and Minoxidil together, and have interactions are studied.

Kenalog and Minoxidil drug interactions.

What are the common drug interactions of Kenalog and Minoxidil, by gender? *:

female:

  1. Anxiety
  2. Headache (pain in head)
  3. Abdominal pain
  4. Blood pressure fluctuation
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Chest pain
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Depression
  10. Dizziness

male:

  1. Drug ineffective
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Alopecia universalis (rapid loss of all hair, including eyebrows and eyelashes)
  4. Arachnoid cyst
  5. Arteriovenous fistula site infection
  6. Chest pain
  7. Haemoglobin decreased
  8. Haemorrhagic disorder (bleeding disorder)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the common drug interactions of Kenalog and Minoxidil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Headache (pain in head)
  3. Abdominal pain
  4. Blood pressure fluctuation
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Chest pain
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Depression
  10. Dizziness

30-39:

  1. Drug ineffective

40-49:

n/a

50-59:

  1. Bone density decreased
  2. Fatigue (feeling of tiredness)
  3. General physical health deterioration (weak health status)
  4. Libido decreased (loss of interest in sex)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Nephropathy (damage to or disease of a kidney)
  7. Osteoporosis (bones weak and more likely to break)
  8. Renal failure (kidney dysfunction)

60+:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Nephropathy (damage to or disease of a kidney)
  4. Osteoporosis (bones weak and more likely to break)
  5. Renal failure (kidney dysfunction)
  6. Bone density decreased
  7. Chronic kidney disease
  8. Drug ineffective
  9. Fatigue (feeling of tiredness)
  10. General physical health deterioration (weak health status)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 2 people, 10.53%
  2. Micturition Disorder (disease of passing urine): 2 people, 10.53%
  3. Diabetes: 2 people, 10.53%
  4. Hiv Infection: 2 people, 10.53%
  5. Alopecia Areata (patchy baldness that typically begins with rapid hair loss): 2 people, 10.53%
  6. Nausea (feeling of having an urge to vomit): 1 person, 5.26%
  7. Lung Disorder (lung disease): 1 person, 5.26%
  8. Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.26%
  9. Stress And Anxiety: 1 person, 5.26%
  10. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Minoxidil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kenalog and Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kenalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kenalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minoxidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and minoxidil (the active ingredients of Kenalog and Minoxidil, respectively), and Kenalog and Minoxidil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: